ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 1 filers reported holding ERASCA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85 | -17.5% | 42,928 | +14.0% | 0.00% | – |
| Q2 2023 | $103 | -38.7% | 37,647 | -32.3% | 0.00% | – |
| Q1 2023 | $168 | -75.6% | 55,598 | -65.2% | 0.00% | – |
| Q4 2022 | $688 | -99.8% | 159,761 | +179.9% | 0.00% | – |
| Q3 2022 | $445,000 | +1248.5% | 57,088 | +852.4% | 0.00% | – |
| Q2 2022 | $33,000 | -71.8% | 5,994 | -56.0% | 0.00% | – |
| Q1 2022 | $117,000 | – | 13,622 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 11,055,554 | $47,649,438 | 12.20% |
| EDBI Pte Ltd | 888,888 | $3,831,107 | 4.88% |
| Cormorant Asset Management, LP | 10,813,246 | $46,605 | 3.12% |
| AH Equity Partners LSV II, L.L.C. | 312,500 | $1,346,875 | 1.64% |
| GREAT POINT PARTNERS LLC | 1,538,461 | $6,630,767 | 1.30% |
| Artal Group S.A. | 4,710,682 | $20,303 | 1.13% |
| PFM Health Sciences, LP | 4,797,460 | $20,677,053 | 0.74% |
| Ghisallo Capital Management LLC | 929,316 | $4,005,352 | 0.71% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 462,972 | $1,995,409 | 0.38% |
| CVI Holdings, LLC | 376,716 | $1,623,646 | 0.21% |